2531 Results (Page 101 of 102)
Healthcare Services Markets Research Reports
Egypt Medication Access Programs Market Analysis
The Egypt Medication Access Programs Market was valued at $15.4 Mn in 2023 and is predicted to grow at a CAGR of 16.1% from 2023 to 2030, to $43.7 Mn by 2030. The key drivers of this industry include disease burden, government initiatives, and patient education and awareness. The industry is primarily dominated by players such as Takeda Pharmaceuticals, Pfizer, Novartis, and Merck among others.
Kenya Medication Access Programs Market Analysis
The Kenya Medication Access Programs Market was valued at $3.8 Mn in 2023 and is predicted to grow at a CAGR of 15.7% from 2023 to 2030, to $10.7 Mn by 2030. The key drivers of this industry include the rising burden of diseases, government initiatives, and technological advancements. The industry is primarily dominated by players such as Takeda Pharmaceuticals, Pfizer, Novartis, and Merck among others.
South Africa Medication Access Programs Market Analysis
The South Africa Medication Access Programs Market was valued at $35.7 Mn in 2023 and is predicted to grow at a CAGR of 15.83% from 2023 to 2030, to $99.8 Mn by 2030. The key drivers of this industry include disease burden, government initiatives, and healthcare infrastructure. The industry is primarily dominated by players such as Gilead Sciences, Takeda Pharmaceuticals, Pfizer, Novartis, and Merck among others.
India Medication Access Programs Market Analysis
The India Medication Access Programs Market was valued at $99.8 Mn in 2023 and is predicted to grow at a CAGR of 17.6% from 2023 to 2030, to $310.5 Mn by 2030. The key drivers of this industry include disease burden, government initiatives, and healthcare expenditure. The industry is primarily dominated by players such as Gilead Sciences, Takeda Pharmaceuticals, Pfizer, Novartis, and Merck among others.
Canada Patient Adherence Programs Market Analysis
The Canada Patient Adherence Programs Market was valued at $1036.5 Mn in 2023 and is predicted to grow at a CAGR of 18% from 2023 to 2030, to $3301.7 Mn by 2030. The key drivers of the market include increasing non-adherence, technological innovations, and cost containment. The prominent players of the Canada Patient Adherence Programs Market are Clearway Health, McKesson Canada, Bayshore Healthcare, Ontario Pharmacists Association (OPA), and the Canadian Agency for Drugs and Technologies in Health (CADTH), among others.
Saudi Arabia Patient Adherence Programs Market Analysis
The Saudi Arabia Patient Adherence Programs Market was valued at $220.3 Mn in 2023 and is predicted to grow at a CAGR of 19.5% from 2023 to 2030, to $766.5 Mn by 2030. The key drivers of the market include. The prominent players of the Saudi Arabia Patient Adherence Programs Market are Jamjoom Pharmaceuticals, Tabuk Pharmaceuticals, AstraZeneca, Jazeera Pharmaceutical Industries, and Sitco Pharma, among others.
UAE Patient Adherence Programs Market Analysis
The UAE Patient Adherence Programs Market was valued at $64.8 Mn in 2023 and is predicted to grow at a CAGR of 19% from 2023 to 2030, to $218.9 Mn by 2030. The key drivers of the market include increasing non-adherence, rising chronic conditions, and an aging population. The prominent players in the UAE Patient Adherence Programs Market are Medspero Pharma, Julphar Gulf Pharmaceuticals, Neopharma, Globalpharma, Medpharma, Avernus Pharma, and Lavasta Pharma, among others.
Brazil Patient Adherence Programs Market Analysis
The Brazil Patient Adherence Programs Market was valued at $323.9 Mn in 2023 and is predicted to grow at a CAGR of 19.0% from 2023 to 2030, to $1094.6 Mn by 2030. The key drivers of the market include increasing non-adherence, rising chronic conditions, and an aging population. The prominent players in the Brazil Patient Adherence Programs Market are Amil, Bradesco Saude, Novartis, Sanofi, and Pfizer, among others.
Mexico Patient Adherence Programs Market Analysis
The Mexico Patient Adherence Programs Market was valued at $194.3 Mn in 2023 and is predicted to grow at a CAGR of 18.25% from 2023 to 2030, to $628.3 Mn by 2030. The key drivers of the market include. The prominent players in the Mexico Patient Adherence Programs Market are Grupo Neolpharma, PiSA Farmaceutica, Liomont, Laboratorios Sanfer, and Laboratorios Sophia, among others.
Spain Patient Adherence Programs Market Analysis
The Spain Patient Adherence Programs Market was valued at $250 Mn in 2023 and is predicted to grow at a CAGR of 17% from 2023 to 2030, to $750.5 Mn by 2030. The key drivers of the market include increasing non-adherence, rising chronic conditions, and an aging population. The prominent players in the Spain Patient Adherence Programs Market are Atrys, Bayer, Boehringer Ingelhem, Novartis, and 3P Biopharmaceuticals, among others.
UK Patient Adherence Programs Market Analysis
The UK Patient Adherence Programs Market was valued at $336.9 Mn in 2023 and is predicted to grow at a CAGR of 16% from 2023 to 2030, to $952 Mn by 2030. The key drivers of the market include increasing non-adherence, rising awareness, and technological innovations. The prominent players of the UK Patient Adherence Programs Market are AstraZeneca, Johnson & Johnson, Bayer, GSK, Merck, and Novartis, among others.
China Patient Adherence Programs Market Analysis
The China Patient Adherence Programs Market was valued at $1041.5 Mn in 2023 and is predicted to grow at a CAGR of 19.5% from 2023 to 2030, to $3624.4 Mn by 2030. The key drivers of the market include increasing non-adherence, rising chronic conditions, and an aging population. The prominent players of the China Patient Adherence Programs Market are, among others
Indonesia Patient Adherence Programs Market Analysis
The Indonesia Patient Adherence Programs Market was valued at $77.7 Mn in 2023 and is predicted to grow at a CAGR of 18% from 2023 to 2030, to $247.6 Mn by 2030. The key drivers of the market include increasing non-adherence, rising chronic conditions, and an aging population. The prominent players in the Indonesia Patient Adherence Programs Market are Kalbe Farma, Dexa Medica, Kimia Farma, Sido Muncul, and Tempo Scan Pacific, among others.
Japan Patient Adherence Programs Market Analysis
The Japan Patient Adherence Programs Market was valued at $805.3 Mn in 2023 and is predicted to grow at a CAGR of 18.5% from 2023 to 2030, to $2642.4 Mn by 2030. The key drivers of the market include rising non-adherence, technological innovations, and healthcare cost containment. The prominent players of the Japan Patient Adherence Programs Market are Takeda Pharmaceutical Company, Astellas Pharma, Daiichi Sankyo, Eisai Co., Ltd., and Otsuka Pharmaceuticals, among others.
Malaysia Patient Adherence Programs Market Analysis
The Malaysia Patient Adherence Programs Market was valued at $20.8 Mn in 2023 and is predicted to grow at a CAGR of 18.2% from 2023 to 2030, to $67.1 Mn by 2030. The key drivers of the market include increasing non-adherence, rising chronic conditions, and technological innovations. The prominent players in the Malaysia Patient Adherence Programs Market are Pharmaniaga, Duopharma Biotech, Apex Healthcare Berhad, GSK, and Merck, among others.
Philippines Patient Adherence Programs Market Analysis
The Philippines Patient Adherence Programs Market was valued at $28.5 Mn in 2023 and is predicted to grow at a CAGR of 18.5% from 2023 to 2030, to $93.5 Mn by 2030. The key drivers of the market include increasing non-adherence, rising chronic conditions, and an aging population. The prominent players in the Philippines Patient Adherence Programs Market are Abbott Laboratories, Ajanta Pharma, Bauch Laboratories, EL Laboratories, Euro-Med Laboratories, and Pascual Laboratories, among others.
Vietnam Patient Adherence Programs Market Analysis
The Vietnam Patient Adherence Programs Market was valued at $64.8 Mn in 2023 and is predicted to grow at a CAGR of 18.23% from 2023 to 2030, to $209.2 Mn by 2030. The key drivers of the market include technological innovations, rising awareness, and an aging population. The prominent players in the Vietnam Patient Adherence Programs Market are Traphaco, Imexpharm, Bidiphar, DHG Pharma, and Ha Tay Pharmaceuticals, among others.
Egypt Patient Adherence Programs Market Analysis
The Egypt Patient Adherence Programs Market was valued at $36.3 Mn in 2023 and is predicted to grow at a CAGR of 19.5% from 2023 to 2030, to $126.2 Mn by 2030. The key drivers of the market include increasing non-adherence, rising chronic conditions, and an aging population. The prominent players in the Egypt Patient Adherence Programs Market are Eva Pharma, Rameda Pharmaceuticals, MUP (Medical Union Pharmaceuticals), Sedico Pharmaceuticals, and EIPICO (Egyptian International Pharmaceutical Industries Co), among others.
Kenya Patient Adherence Programs Market Analysis
The Kenya Patient Adherence Programs Market was valued at $9.1 Mn in 2023 and is predicted to grow at a CAGR of 19.1% from 2023 to 2030, to $30.8 Mn by 2030. The key drivers of the market include increasing non-adherence, rising chronic conditions, and an aging population. The prominent players in the Kenya Patient Adherence Programs Market are Aventis Pasteur, Bayer East Africa Ltd, Eli-Lilly, GSK, and Novartis, among others.
South Africa Patient Adherence Programs Market Analysis
The South Africa Patient Adherence Programs Market was valued at $84.2 Mn in 2023 and is predicted to grow at a CAGR of 19.23% from 2023 to 2030, to $288.5 Mn by 2030. The key drivers of the market include increasing non-adherence, rising chronic conditions, and increased demand for personalized healthcare technologies. The prominent players in the South Africa Patient Adherence Programs Market are Alura Pharmaceuticals, Aspen Pharma Group, BFC Pharma, Innovata Pharmaceuticals, Novexpharma, Novartis South Africa, and Pharmed Pharmaceuticals, among others.
India Patient Adherence Programs Market Analysis
The India Patient Adherence Programs Market was valued at $235.6 Mn in 2023 and is predicted to grow at a CAGR of 21% from 2023 to 2030, to $894.8 Mn by 2030. The key drivers of the market include increasing non-adherence, rising chronic conditions, and an aging population. The prominent players of the India Patient Adherence Programs Market are Cipla, Dr. Reddy’s Laboratories, Sun Pharma, Cadila Healthcare, Lupin Pharmaceuticals, and Aurobindo Pharma, among others.
Canada Hospital Market Analysis
The Canada Hospital Market was valued at $439.96 Bn in 2023 and is predicted to grow at a CAGR of 7.6% from 2023 to 2030, to $734.69 Bn by 2030. The key drivers of this industry rise in the geriatric population, technological advancements, and government funding. The key players in the industry are Vancouver Coastal Health, Hamilton Health Sciences, London Health Sciences Centre, and Queen Elizabeth II Health Sciences Centre among others.
Saudi Arabia Hospital Market Analysis
The Saudi Arabia Hospital Market was valued at $93.49 Bn in 2023 and is predicted to grow at a CAGR of 9.1% from 2023 to 2030, to $172.01 Bn by 2030. The key drivers of this industry are burden of chronic diseases, government investments, and focus on preventive care. The key players in the industry are Dr. Sulaiman Al Habib Medical Group, Saudi German Hospitals Group, Elaj Group, and Kingdom Hospital among others.
UAE Hospital Market Analysis
The UAE Hospital Market was valued at $27.50 Bn in 2023 and is predicted to grow at a CAGR of 8.6% from 2023 to 2030, to $48.99 Bn by 2030. The key drivers of this industry prevalence of chronic disease, privatization of healthcare, and preventive care. The key players in the industry are Mediclinic Middle East, Aster DM Healthcare, Al Zahra Hospital, and Thumbay Group among others.
Brazil Hospital Market Analysis
The Brazil Hospital Market was valued at $137.49 Bn in 2023 and is predicted to grow at a CAGR of 8.6% from 2023 to 2030, to $244.95 Bn by 2030. The key drivers of this industry are rise in the geriatric population, technological advancement, and government initiatives. The key players in the industry are Hospital São Rafael, Rede D'Or São Luiz, Hospital Alemão Oswaldo Cruz, and Hospital Samaritano among others.